Information
The Rare Diseases and Orphan Drugs Journal has received funding from the European Union Seventh Framework Programme (FP7/2007-2013) under Grant Agreement № 305690: RARE-Bestpractices project: www.rarebestpractices.eu. Sole responsibility lies with the authors and the European Comission is not responsible for any use that may be made of the information contained therein.
